Published Mar 12, 2021
#452 Learning about Teplizumab
Francisco Leon, co-founder of Provention Bio, delves into his journey in autoimmune research, the groundbreaking impact of teplizumab on type 1 diabetes treatment, and the role of viruses and early interventions in advancing health outcomes.
Topics covered
Popular Clips
Questions from this episode
- Asked by 39 people
- Asked by 27 people
- Asked by 15 people
- Asked by 9 people
- Asked by 1 person
Episode Highlights
Related Episodes
#808 Teplizumab Trial Participant
Answers 383 questions
#382 Stem Cells and Type 1 Diabetes
Answers 383 questions
#529 Gail Force
Answers 383 questions
#1109 Type 3c Diabetes
Answers 383 questions
#1073 Italian Holiday
Answers 383 questions
#803 The Conversation Reveals All
Answers 383 questions
#962 Baby Catcher
Answers 383 questions
#413 Thyroid Disease Explained
Answers 383 questions
#649 Quadoimmune
Answers 383 questions#928 Juicebox Assistance
Answers 383 questions
#721 Cutting It Up
Answers 383 questions
#749 Jeremy Gets It
Answers 383 questions
#1090 Diabetes Breakdown
Answers 383 questions
#724 Downton Podcast
Answers 383 questions
#898 Breaker Breaker
Answers 383 questions